Arich Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 10, 2019 at 04:25 pm EST
Share
Arich Enterprise Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 312.711 million compared to TWD 358.576 million a year ago. Net income was TWD 10.720 million compared to TWD 15.213 million a year ago. Basic earnings per share was TWD 0.24 compared to TWD 0.34 a year ago. For the nine months, sales was TWD 912.539 million compared to TWD 1,044.657 million a year ago. Net income was TWD 47.009 million compared to TWD 42.489 million a year ago. Basic earnings per share was TWD 1.05 compared to TWD 0.95 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
